Valuation: BELE LIFEUT

Market Cap 46.6M 40.72M 37.57M 34.63M 65.28M 4.49B 66.73M 449M 177M 2.2B 175M 171M 7.57B P/E 2022 *
-
P/E 2023 210x
Enterprise Value 46.65M 40.77M 37.62M 34.68M 65.36M 4.49B 66.81M 450M 177M 2.2B 175M 171M 7.57B EV / Sales 2022 *
-
EV / Sales 2023 -
Free-Float
-
Yield 2022 *
-
Yield 2023 -

Financials

2022 2023
Net sales - -
Net income -35.39K -30.93K -28.54K -26.3K -49.58K -3.41M -50.68K -341K -134K -1.67M -133K -130K -5.75M 404K 353K 326K 300K 566K 38.88M 578K 3.89M 1.53M 19.04M 1.52M 1.48M 65.56M
Net Debt 1.09M 955K 881K 812K 1.53M 105M 1.56M 10.53M 4.14M 51.53M 4.1M 4.01M 177M 56.58K 49.45K 45.63K 42.06K 79.27K 5.45M 81.03K 545K 215K 2.67M 212K 208K 9.19M
Logo BELE LIFEUT
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company has business operations in the United States, Europe and South Korea.
Employees
-
Sector
-